The Claim
In adults with irritable bowel syndrome, double-blind placebo treatment is not significantly associated with baseline levels of visceral sensitivity or pain catastrophizing.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adults with irritable bowel syndrome, receiving a placebo without knowing it does not correlate with their baseline levels of internal pain sensitivity or tendency to focus on pain.
See the scientific wording
In adults with irritable bowel syndrome, double-blind placebo treatment shows no significant association with baseline levels of visceral sensitivity or pain catastrophizing, suggesting that psychological traits influencing open-label placebo response do not play a detectable role in placebo effects under deception.
When a person takes a fake treatment without knowing it's fake, their body responds based on learned expectations tied to medical rituals, not their current level of gut sensitivity or negative thoughts about pain.
What the research says
1 studyWhen people with IBS take a fake pill without knowing it’s fake, whether they’re anxious about their gut or feel hopeless doesn’t affect if they feel better. But if they know it’s fake, those traits do matter. So, hiding the truth makes psychological traits irrelevant to the placebo effect.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.